March 18, 2021
Startup Behind AstraZeneca Covid-19 Vaccine Raises $168 Million in Step Toward IPO – WSJ
LONDON—The Oxford startup behind AstraZeneca PLC’s Covid-19 vaccine has raised $168 million in new funding,…
March 18, 2021
8 recent health IT, innovation partnerships
Here are eight recent health IT vendor contracts and go-lives accelerating digital transformation efforts at…
March 17, 2021
Biohealth Capital Fund Introductory Video
March 17, 2021
Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results
OXFORD, United Kingdom, March 17, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical…
March 15, 2021
How Remote Work Is Reshaping America’s Urban Geography – WSJ
A year ago, just before the start of pandemic lockdowns, some 10% or less of…
March 15, 2021
J&J plans to produce up to 3 billion doses of vaccine next year, United States News & Top Stories – The Straits Times
CHICAGO/FRANKFURT • The chief scientist of Johnson & Johnson said the company expects to produce…
March 15, 2021
Opinion | A Vaccine Maker’s Investment: Emergent BioSolutions Responds – The New York Times
The past year has been the most important in Emergent BioSolutions’ history. We’ve had the…